Prescribing Information
About Trelstar
Understanding Prostate Cancer
Information For Healthcare Professionals
  About TRELSTAR
  Administering TRELSTAR
  Oder TRELSTAR
  Reimbursement & Support Programs
  RRequest Additional Information
  Additional Resources
  TRELSTAR Events/CME
  Prescribing Information
Order TRELSTAR
TRELSTAR® Events/CME

Tradeshows
The following is a list of tradeshows we will be attending. We look forward to seeing you there. If you have any questions regarding TRELSTAR or any of the listed events please fill out our request form and we will have someone contact you.

2008 Tradeshow schedule*:


Date Location Convention Name

February
2/28–3/2 Marriott Waterside
Tampa, FL
Society Urologic Nurses Association -SPRING

March
3/6–3/9 Manchester Grand Hyatt
San Diego, CA
AUA Southeastern Sectional Meeting

May
5/17–5/22 Orange County Convention Center
Orlando, FL
American Urological Association

September
9/17–9/21 Hyatt Regency
Santa Ana Pueblo, NM
AUA North Eastern Sectional Meeting
9/18–9/21 Grand Hyatt Manchester
San Diego, CA
AUA South Central Sectional Meeting
9/24–9/27 Hyatt Regency
Chicago, IL
AUA North Central Sectional Meeting
9/24–9/28 Westin Rio Mar Hotel
Rio Grande, Puerto Rico
AUA New England Sectional Meeting
9/25–9/28 Cambridge, MD AUA Mid-Atlantic Sectional Meeting

October
10/3–10/6 Marriott Hotel
Philadelphia, PA
Society Urologic Nurses Association -FALL
10/26–10/30 Portola Plaza Hotel
Monterey, CA
AUA Western Sectional Meeting

CME Opportunities
Watson is committed to providing the professional community with current, relevant, and valuable disease-state information related to prostate treatment. We are dedicated to supporting educational programs and initiatives that advance the treatment of urological diseases.

To receive an invitation or be notified when CME programs become available, click here.

* Events subject to change without notice.

Indications and Usage
TRELSTAR® Depot and TRELSTAR® LA are indicated in the palliative treatment of advanced prostate cancer. TRELSTAR Depot or TRELSTAR LA offer an alternative treatment for prostate cancer when orchiectomy or estrogen administration are either not indicated or unacceptable to the patient.
 
Safety Information
The most commonly reported adverse events associated with the use of TRELSTAR® Depot/TRELSTAR® LA included hot flushes (58.6%/73.0%), skeletal pain (12.1%/13.2%), impotence (7.1%/2.3%), headache (5.0%/6.9%), leg pain (2.1%/5.2%), and edema in legs (0.0%/6.3%) . TRELSTAR is contraindicated in women who are or may become pregnant as well as patients who are hypersensitive to triptorelin, other LHRH agonists, or LHRH . Infrequent postmarketing reports of anaphylactic shock and angioedema have been received since 1986 (global experience) . As with all LHRH agonists, triptorelin causes an initial transient increase in testosterone levels. Patients may experience the onset or exacerbation of symptoms during this period, including bone pain, neuropathy, hematuria, spinal cord compression, or urethral or bladder outlet obstruction. Patients with metastatic vertebral lesions and/or urinary tract obstruction should be closely observed.